Kerri Glassner VIEW CLINICAL PROFILE

Kerri Glassner, DO

Assistant Professor of Clinical Medicine, Academic Institute
Houston Methodist
Weill Cornell Medical College


VIEW CLINICAL PROFILE
Publications

Development of Shingles on Tofacitinib Despite Completion of Recombinant Varicella-Zoster Virus Vaccine Series
Thomas, B, Moskow, J, Garza, M, Warren, B, Abraham, B & Glassner, K 2023, , ACG case reports journal, vol. 10, no. 12, pp. e01221. https://doi.org/10.14309/crj.0000000000001221

Patient Attitudes and Barriers to Endoscopy During the COVID-19 Pandemic
Ergun, GA, Abughazaleh, S, Glassner, K, Kuhlman, S & Ordonez, A 2023, , Digestive Diseases and Sciences, vol. 68, no. 6, pp. 2303-2314. https://doi.org/10.1007/s10620-023-07911-7

Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes
Irani, M, Fan, C, Glassner, K & Abraham, BP 2023, , Clinical and Experimental Gastroenterology, vol. 16, pp. 21-28. https://doi.org/10.2147/CEG.S367086

Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults—A population-level analysis in the national health interview survey
Nasir, K, Acquah, I, Dey, AK, Agrawal, T, Hassan, SZ, Glassner, K, Abraham, BP, Quigley, EMM, Blankstein, R, Virani, SS, Blaha, MJ, Valero-Elizondo, J, Cainzos-Achirica, M & Mehta, NN 2022, , American Journal of Preventive Cardiology, vol. 9, 100316. https://doi.org/10.1016/j.ajpc.2022.100316

Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician
Saleh, A, Ansari, U, Abughazaleh, S, Glassner, K & Abraham, BP 2022, , Biologics: Targets and Therapy, vol. 16, pp. 67-83. https://doi.org/10.2147/BTT.S335697

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
Alayo, QA, Fenster, M, Altayar, O, Glassner, KL, Llano, E, Clark-Snustad, K, Patel, A, Kwapisz, L, Yarur, AJ, Cohen, BL, Ciorba, MA, Thomas, D, Lee, SD, Loftus, EV, Fudman, DI, Abraham, BP, Colombel, JF & Deepak, P 2022, , Crohns and Colitis 360, vol. 4, no. 1, otac002, pp. otac002. https://doi.org/10.1093/crocol/otac002

Positioning biologics and small molecules in the management of moderate to severe ulcerative colitis
Abraham, B & Glassner, K 2021, , Current opinion in gastroenterology, vol. 37, no. 4, pp. 344-350. https://doi.org/10.1097/MOG.0000000000000738

Risk factors for and frequency of ct scans, steroid use, and repeat visits in inflammatory bowel disease patients seen at a single-center emergency department: A retrospective cohort study
Euers, L, Abughazaleh, S, Glassner, K, Gajula, P, Jones-Pauley, M, Ezeana, C, Puppala, M, Wang, L, Wong, S, Oglat, A, Nickerson, S & Abraham, BP 2021, , Journal of Clinical Medicine, vol. 10, no. 12, 2679. https://doi.org/10.3390/jcm10122679

Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease
Agrawal, T, Acquah, I, Dey, AK, Glassner, K, Abraham, B, Blankstein, R, Virani, SS, Blaha, MJ, Valero-Elizondo, J, Mehta, N, Quigley, EM, Cainzos-Achirica, M & Nasir, K 2021, , American journal of preventive cardiology, vol. 6, pp. 100171. https://doi.org/10.1016/j.ajpc.2021.100171

Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease
Agrawal, T, Acquah, I, Dey, AK, Glassner, K, Abraham, BP, Blankstein, R, Virani, SS, Blaha, MJ, Valero-Elizondo, J, Mehta, N, Quigley, EMM, Cainzos-Achirica, M & Nasir, K 2021, , American Journal of Preventive Cardiology, vol. 6, 100171. https://doi.org/10.1016/j.ajpc.2021.100171

Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week
Cainzos-Achirica, M, Glassner, K, Zawahir, HS, Dey, AK, Agrawal, T, Quigley, EMM, Abraham, BP, Acquah, I, Yahya, T, Mehta, NN & Nasir, K 2020, , Journal of the American College of Cardiology, vol. 76, no. 24, pp. 2895-2905. https://doi.org/10.1016/j.jacc.2020.10.027

The use of combination biological or small molecule therapy in inflammatory bowel disease: A retrospective cohort study
Glassner, K, Oglat, A, Duran, A, Koduru, P, Perry, C, Wilhite, A & Abraham, BP 2020, , Journal of Digestive Diseases, vol. 21, no. 5, pp. 264-271. https://doi.org/10.1111/1751-2980.12867

Herpes Simplex Virus-2 Hepatitis: A Case Report and Review of the Literature
Ahmed, A, Granillo, A, Burns, E, Glassner, K, Naseem, N, Force, C, Crumley, SM & Drews, A 2020, , Case Reports in Medicine, vol. 2020, 8613840. https://doi.org/10.1155/2020/8613840

The microbiome and inflammatory bowel disease
Glassner, KL, Abraham, BP & Quigley, EMM 2020, , Journal of Allergy and Clinical Immunology, vol. 145, no. 1, pp. 16-27. https://doi.org/10.1016/j.jaci.2019.11.003

The use of vedolizumab in pregnancy and breastfeeding in women with inflammatory bowel disease
Glassner, K & Abraham, BP 2019, , Practical Gastroenterology, vol. 43, no. 9, pp. 13-18.

Autoimmune liver disease and the enteric microbiome
Glassner, K, Quigley, EMM, Franco, L & Victor, DW 2018, , AIMS Microbiology, vol. 4, no. 2, pp. 334-346. https://doi.org/10.3934/MICROBIOL.2018.2.334

VIEW FULL PUBLICATIONS